Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02132403
What this trial is testing

(PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Illinois at Chicago 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940286
What this trial is testing

Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaResectable Pancreatic AdenocarcinomaStage IA Pancreatic Cancer AJCC v8+3 more
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Study completedNCT01064622
What this trial is testing

Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage IV Pancreatic Cancer AJCC v6 and v7
National Cancer Institute (NCI) 118
Testing effectiveness (Phase 2)Study completedNCT00003951
What this trial is testing

DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Daiichi Sankyo 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT05249101
What this trial is testing

Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
CG Pharmaceuticals, Inc 70
Large-scale testing (Phase 3)UnknownNCT03317886
What this trial is testing

Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreaticoduodenectomyMesenteric Approach
Wakayama Medical University 354
Testing effectiveness (Phase 2)Study completedNCT01032057
What this trial is testing

Gemcitabine, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Pancreatic Cancer
Lisette Nixon 114
Early research (Phase 1)Study completedNCT00056537
What this trial is testing

ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer

Who this might be right for
Non-Small-Cell Lung CarcinomaRenal Cell CarcinomaPancreatic Cancer
Active Biotech AB 44
Not applicableStudy completedNCT05547074
What this trial is testing

A New Prognostic Score Model for Pancreatic Ductal Adenocarcinoma

Who this might be right for
Neoplasms Pancreatic
Zhejiang University 302
Post-approval studies (Phase 4)Active Not RecruitingNCT05634720
What this trial is testing

Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Duke University 20
Early research (Phase 1)Looking for participantsNCT06639724
What this trial is testing

Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
University of California, San Diego 36
Not applicableStudy completedNCT03693378
What this trial is testing

IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups

Who this might be right for
Pancreatic Ductal AdenocarcinomaFamilial Pancreatic CancerFAMMM - Familial Atypical Mole Malignant Melanoma Syndrome
Immunovia, Inc. 1,349
Testing effectiveness (Phase 2)Looking for participantsNCT03175224
What this trial is testing

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced CancerRenal Cancer+15 more
Apollomics Inc. 497
Not applicableNot Yet RecruitingNCT06276738
What this trial is testing

The LINFU® U.S. Registry in Patients With Clinical Signs and/or Symptoms of Disease

Who this might be right for
Pancreatic CancerJaundiceAbdominal Neoplasm
Adenocyte, LLC 1,000
Not applicableUnknownNCT01438385
What this trial is testing

Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders

Who this might be right for
Ampullary CancerDuodenal CancerBile Duct Cancer+20 more
Weill Medical College of Cornell University 12,000
Not applicableStudy completedNCT03032913
What this trial is testing

Diagnostic Accuracy of Circulating Tumor Cells (CTCs) and Onco-exosome Quantification in the Diagnosis of Pancreatic Cancer - PANC-CTC

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
University Hospital, Bordeaux 52
Early research (Phase 1)Study completedNCT02048384
What this trial is testing

Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Early research (Phase 1)Study completedNCT02620800
What this trial is testing

Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreas Adenocarcinoma
Celgene 12
Early research (Phase 1)Study completedNCT02368860
What this trial is testing

OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
National Cancer Centre, Singapore 33
Not applicableUnknownNCT04365049
What this trial is testing

Nab-Paclitaxel and Gemcitabine Plus Camrelizumab and Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma

Who this might be right for
PDAC - Pancreatic Ductal Adenocarcinoma
Sun Yat-sen University 100
Next Page